Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Class A common stock, $0.001 par value per share
Shares outstanding
71,297,491
Total 13F shares
14,513,290
Share change
+14,513,290
Total reported value
$186,104,000
Price per share
$13.25
Number of holders
21
Value change
+$186,104,000
Number of buys
21

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) as of Q2 2021

As of 30 Jun 2021, Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,513,290 shares. The largest 10 holders included FMR LLC, Abingworth LLP, Sofinnova Investments, Inc., CITADEL ADVISORS LLC, KPCB XVI Associates, LLC, Octagon Capital Advisors LP, Alphabet Inc., MILLENNIUM MANAGEMENT LLC, Parkman Healthcare Partners LLC, and VANGUARD GROUP INC. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.